1. AODTH-006 Hypermutation and mutational signatures in inflammatory bowel disease-associated colorectal cancers. (17th June 2017) Authors: Din, S; Wong, K; Mueller, MF; Oniscu, A; James, H; Black, CJ; Miller, ML; Jiménez-Sánchez, A; Rabbie, R; Rashid, M; Satsangi, J; Adams, DJ; Arends, MJ Journal: Gut Issue: Volume 66(2017)Supplement 2 Page Start: A201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DOP68 CD-TREAT diet induces remission and improves quality of life in an open label trial in children and adults with active Crohn's Disease. (21st January 2022) Authors: Svolos, V; Hansen, R; Russell, R; Gaya, D R; John Paul, S; Macdonald, J; Nichols, B; Papadopoulou, R; Logan, M; Mckirdy, S; Gervais, R; Ijaz, U; Milling, S; Shields, S; Wilson, D; Henderson, P; Din, S; Ho, G T; Gerasimidis, K Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OC-069 Constitutive Activation of the DNA Damage Response Pathway in Cancer Represents a Deregulated Pathway. (4th June 2013) Authors: Din, S; Hupp, T Journal: Gut Issue: Volume 62(2013)Supplement 1 Page Start: A30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OP33 Results of a randomised controlled trial to evaluate Interleukin 1 blockade with anakinra in patients with acute severe ulcerative colitis (IASO). (30th January 2023) Authors: Raine, T; Vaja, S; Subramanian, S; Brezina, B; Probert, C S; Steel, A; Lofthouse, M; Speight, R A; Lamb, C; Sebastian, S; Kane, J; Thut, J; Din, S; Arnott, I; Smith, L; Galea, J; Hendy, P; Flores, L; Selinger, C; Onoviran, F Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P127 Inflammatory Bowel Disease-associated colorectal cancers: retrospective cohort study from a tertiary centre surveillance programme over 10 years. (30th January 2023) Authors: Porter, R; Gillespie, S L; Song, M; Ball, G; Crawford, A; Churchhouse, A; Gardner, M; Plevris, N; Chuah, C S; Brindle, W; Watson, E; Jenkinson, P; Fulforth, J; Kedziora, M; Dickson, B; Megan, A; Jones, G R; Din, S Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P140 Challenges in colonoscopic surveillance in chronic IBD. (25th January 2019) Authors: Gillespie, S-L; Singh-Clark, N; Shand, A; Lees, C; Arnott, I; Ho, G-T; Watson, E; Noble, C; Din, S Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S160 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P380 Changes in faecal microbiome and metabolome are more pronounced in Crohn's disease patients who adhered to the CD-TREAT diet and responded by calprotectin. (30th January 2023) Authors: Svolos, V; Hansen, R; Russell, R K; Gaya, D R; Seenan, J P; Macdonald, J; Wilson, D; Henderson, P; Din, S; Ho, G T; Quince, C; Ijaz, U Z; Milling, S; Nichols, B; Papadopoulou, R; McKirdy, S; Gervais, L; Shields, S; Gerasimidis, K Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i513 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P671 Experiences of using vedolizumab in the treatment of inflammatory bowel disease in the East Midlands: a retrospective observational study. (25th January 2019) Authors: White, J R; Din, S; Ingram, R; Foley, S; Alam, M A; Robinson, R; Francis, R; Tucker, E; Jalal, M; Elphick, D; Atallah, E; Norman, A; Amin, M; Sajjad, A; Heggs, N; Meadowcroft, S; Moran, G Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S454 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P713 Effects of vedolizumab on health-related quality of life, work productivity and patient concerns in patients with ulcerative colitis and Crohn's disease in the UK and Ireland: OCTAVO cohort 2. (15th January 2020) Authors: Parkes, G; Akbar, A; Beales, I; Buckley, M; Creed, T; Din, S; Fraser, A; Plevris, N; Meadowcroft, S; Owen, G; Heggs, N Journal: Journal of Crohn's and colitis Issue: Volume 14(2020)Supplement 1 Page Start: S575 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PTH-134 Experiences of using vedolizumab in the treatment of inflammatory bowel disease in the east midlands. (June 2019) Authors: White, JR; Din, S; Ingram, R; Foley, S; Alam, M; Robinson, R; Francis, R; Tucker, E; Jalal, M; Elphick, D; Atallah, E; Norman, A; Amin, M; Sajjad, A; Heggs, N; Meadowcroft, S; Moran, GW Journal: Gut Issue: Volume 68(2019)Supplement 2 Page Start: A102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗